Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 82.88B | 76.89B | 77.96B | 66.85B | 59.98B |
Gross Profit | 15.71B | 15.46B | 14.89B | 13.21B | 12.90B |
EBITDA | 7.54B | 7.56B | 8.57B | 7.99B | 8.17B |
Net Income | 2.23B | 1.51B | 3.15B | 4.66B | 3.82B |
Balance Sheet | |||||
Total Assets | 76.28B | 76.41B | 70.66B | 66.87B | 56.87B |
Cash, Cash Equivalents and Short-Term Investments | 17.12B | 18.70B | 17.69B | 13.82B | 15.46B |
Total Debt | 10.51B | 13.59B | 11.18B | 7.77B | 9.15B |
Total Liabilities | 24.25B | 26.03B | 23.43B | 22.54B | 20.67B |
Stockholders Equity | 51.94B | 50.30B | 47.16B | 44.27B | 36.16B |
Cash Flow | |||||
Free Cash Flow | 4.76B | 41.00M | 2.08B | -1.59B | 771.00M |
Operating Cash Flow | 7.24B | 4.82B | 7.31B | 3.68B | 5.14B |
Investing Cash Flow | -4.08B | -5.13B | -5.86B | -5.97B | -4.62B |
Financing Cash Flow | -4.62B | -260.00M | 1.53B | 171.00M | 1.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥33.13B | 14.87 | 3.38% | 7.79% | 47.38% | ||
62 Neutral | £510.88M | 22.63 | -8.61% | 186.64% | 4.26% | -25.59% | |
― | $192.62M | 122.17 | 0.29% | 0.03% | ― | ― | |
63 Neutral | ¥31.64B | 38.50 | 8.20% | -3.62% | -81.77% | ||
― | ¥31.61B | 9.34 | 1.88% | ― | ― | ||
81 Outperform | ¥30.86B | 10.61 | 5.43% | 1.17% | 8.92% |